Cover Image
市場調查報告書

越南的IVD (體外診斷) 市場

The IVD Market in Vietnam

出版商 Kalorama Information 商品編碼 338592
出版日期 內容資訊 英文 43 Pages
訂單完成後即時交付
價格
Back to Top
越南的IVD (體外診斷) 市場 The IVD Market in Vietnam
出版日期: 2015年08月19日 內容資訊: 英文 43 Pages
簡介

越南近幾年展現著迅速的經濟發展。外國投資、工資、貿易、工業化及旅遊觀光事業的擴大,帶來比亞洲及其他許多經濟國高的經濟發展。由於人口多,醫療基礎設施擴大,經濟成長,及國際IVD企業的存在,越南成為對IVD (體外診斷) 的競爭企業、投資者來說具高度興趣的國家。

本報告提供越南的IVD (體外診斷) 產業的現狀相關分析、市場整體及各市場區隔的市場規模、成長率相關資料、影響市場的主要課題、趨勢,及主要企業的活動等系統性資訊。

第1章 摘要整理

第2章 簡介

  • 醫療費
  • 醫療組織
  • 保險
  • 臨床實驗室

第3章 趨勢

  • 越南人的健康狀態
  • 糖尿病
  • 結核
  • 中風、冠狀動脈心臟病
  • HIV/AIDS
  • 癌症
  • 流感
  • 越南的醫療觀光
  • 美國CDC改善越南的醫療實驗室的設計、品質
  • 行賄受賄貪污
  • 越南的國際IVD企業
  • bioMerieux
  • Roche
  • Abbott Laboratories, S.A.
  • Siemens Healthcare
  • Sysmex

第4章 越南的IVD市場

  • 市場規模、成長率
  • IVD市場:各地區
  • 臨床化學
  • 照護現場糖尿病
  • 照護現場、其他
  • 免疫檢測、感染疾病以及其他
  • 尿液檢查
  • 分子診斷
  • 凝血
  • 組織學
  • 血液學
  • 血液檢驗、分型
  • 流動化學
  • 市場整體:各市場區隔

圖表清單

目錄
Product Code: KLI5670825

Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. A large population, growing healthcare infrastructure, growing economy and the presence of international IVD companies make the nation of interest to competitors and investors in in vitro diagnostics.

Vietnam spends a bit higher as a percentage of its GDP than its neighbors and the government is making significant investments in national healthcare infrastructure. The country's investment in healthcare has attracted the attention of major IVD competitors. This report places Vietnam and its IVD market in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to health expenditures and diagnostics.

The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. The report takes an in-depth look at the market, providing data on the size and growth of the total Vietnamese market as well as of the following Vietnamese market segments:

  • Clinical Chemistry
  • Microbiology-ID/AST
  • Microbiology-Molecular
  • POC Glucose
  • Other Point of Care
  • Immunoassays Infectious Disease
  • Other Immunoassays
  • Urinalysis
  • Molecular Diagnostics
  • Coagulation
  • Histology
  • Hematology
  • Blood Testing and Typing
  • Flow Cytometry

The IVD Market in Vietnam presents the main issues and trends affecting this market, influencing its move into the future. The report presents eight major conclusions regarding the Vietnamese market as well.

The report provides detailed information regarding the IVD industry and company activity in Vietnam. Recent activity of international IVD Companies in Vietnam is presented. Companies discussed include:

  • bioMerieux
  • Roche
  • Abbott Laboratories, S.A.
  • Siemens Healthcare
  • Sysmex

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Size of the Healthcare Market and Forecast
  • Conclusions

TWO: INTRODUCTION

  • Healthcare Spending
  • Organization of Healthcare
  • Insurance
  • Clinical Laboratories

THREE: TRENDS

  • Health Status of Vietnamese
  • Diabetes
  • Tuberculosis
  • Stroke and Coronary Heart Disease
  • HIV/AIDS
  • Cancer
  • Influenza
  • Vietnam Medical Tourism
  • U.S. CDC Improves Design and Quality of Medical Laboratories in Vietnam
  • Bribery Scandal
  • International IVD Companies in Vietnam
  • bioMerieux
  • Roche
  • Abbott Laboratories, S.A.
  • Siemens Healthcare
  • Sysmex

FOUR: IVD MARKET IN VIETNAM

  • Size of the Market and Growth
  • IVD Market by Region
  • Clinical Chemistry
  • Point of Care Diabetes
  • Point of Care, Other
  • Immunoassays, Infectious Disease and Other
  • Urinalysis
  • Molecular Diagnostics
  • Coagulation
  • Histology
  • Hematology
  • Blood Testing and Typing
  • Flow Cytometry
  • Total Market by Segment

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: Population of Vietnam
  • Figure 1-2: Population and GDP Growth Compared, 2000-2015
  • Figure 1-3: Vietnam IVD Market, 2014 and 2019 ($millions)

TWO: INTRODUCTION

  • Figure 2-1: Urban Population of Vietnam Versus Other Countries, Percent(Vietnam,Thailand, Malaysia, China)
  • Figure 2-2: Births Rates by Select Country, 2014 Estimates (Singapore, Germany, Japan,Taiwan, Greece, Italy, Switzerland, Canada, Spain, Thailand, Australia, United Kingdom,Sweden, China, France, Russia, United states, Brazil, Vietnam, Indonesia, Argentina, Turkey,Mexico, venezuela, South Africa, India, Malaysia, Pakistan, Philippines, Iraq, Afghanistan,Mali, Niger)
  • Figure 2-3: Asia Pacific Region: Aging Populations by Year and Select Country--2007, 2014,2021 (India, China, Indonesia, Pakistan, Philippines, Vietnam, Iran, Afghanistan, Japan, Iraq,Thailand, S. Korea, Malaysia, Australia, Taiwan, N. Korea, Singapore, ROAP)
  • Figure 2-4: Vietnam Population Compared (Singapore, Indonesia, Thailand, Laos, Cambodia,Vietnam, Australia)
  • Figure 2-5: Vietnam Economy Compared (Singapore, Indonesia, Thailand, Laos, Cambodia,Vietnam, Australia)
  • Table 2-1: Vietnam Major Cities Population (Ho Chi Minh City, Hanoi, Haiphong, Đà Nang,Can Thơ, Biên Hòa City, Nha Trang, Buôn Ma Thuot, Hue)
  • Figure 2-6: Healthcare Spending as a Percentage of GDP Compared, Vietnam vs. Other Nations (United States, Germany, Brazil, Vietnam, China, Thailand, India, Philippines,Singapore, Malaysia)
  • Figure 2-7: Hospitals in Vietnam, 2007-2013
  • Figure 2-8: Physicians, Assistants, Nurses in Vietnam, 2009-2013
  • Table 2-2: Healthcare System Capacities - Vietnam and Comparison Countries(Australia,Brazil, China, France, Germany, India, Indonesia, South Korea, Mexico, Nigeria, Poland,Russia, South Africa, Thailand, Turkey, United States, Vietnam)
  • Figure 2-9: Number of Patient Beds, 2009-2013
  • Table 2-3: Out-Of-Pocket, Other Private and Government Healthcare Expenditures in BRIC and Comparison Countries (South Africa, France, United Kingdom, United States, Germany,Thailand, Turkey, Japan, Australia, Italy, Poland, Argentina, Brazil, South Korea, China,Russia, Mexico, Indonesia, Vietnam, India, Nigeria)

THREE: TRENDS

  • Figure 3-1: Prevalence of Diabetes in Adults by Age, 2014

FOUR: IVD MARKET IN VIETNAM

  • Figure 4-1: Vietnam IVD Market, 2014 and 2019
  • Figure 4-2: Regional IVD Markets in Vietnam (South Central Coast, Mekong River Delta, Red
  • River Delta, Southeast, Northeast, Central Highlands, North Central Coast, South Central Coast)
  • Figure 4-3: Vietnam Clinical Chemistry Market, 2014 and 2019
  • Figure 4-4: Vietnam Point of Care Diabetes Market, 2014 and 2019
  • Figure 4-5: Vietnam Point of Care, Other Market, 2014 and 2019
  • Figure 4-6: Vietnam Immunoassays, Infectious Disease and Other Market, 2014 and 2019
  • Figure 4-7: Vietnam Urinalysis Market, 2014 and 2019
  • Figure 4-8: Vietnam Molecular Diagnostics Market, 2014 and 2019
  • Figure 4-9: Vietnam Coagulation Market, 2014 and 2019
  • Figure 4-10: Vietnam Histology Market, 2014 and 2019
  • Figure 4-11: Vietnam Hematology Market, 2014 and 2019
  • Figure 4-12: Vietnam Blood Testing and Typing Market, 2014 and 2019
  • Figure 4-13: Vietnam Flow Ctyometry Market, 2014 and 2019
  • Table 4-1: IVD Market in Vietnam by Segment (Clinical Chemistry, Microbiology-ID/AST,Microbiology-Molecular, POC Glucose, Other Point of Care, Immunoassays Infectious Disease, Other Immunoassays, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry, Total)
Back to Top